{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:10:32Z","timestamp":1794967832423,"version":"4.9.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.drugalcdep.2022.109356","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T11:16:11Z","timestamp":1644578171000},"page":"109356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD"],"prefix":"10.1016","volume":"233","author":[{"given":"Christopher R.","family":"Nicholas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie B.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhpreet S.","family":"Klaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berra","family":"Yazar-Klosinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick","family":"Doblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2022.109356_bib1","series-title":"BDI-II: Beck Depression Inventory Manual","author":"Beck","year":"1996"},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109356_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000081413","article-title":"Evaluation of the drug use disorders identification test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample","volume":"11","author":"Berman","year":"2005","journal-title":"Eur. Addict. Res."},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109356_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/15504263.2014.989653","article-title":"PTSD and substance use disorder among veterans: characteristics, service utilization and pharmacotherapy","volume":"11","author":"Bowe","year":"2015","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.drugalcdep.2022.109356_bib4","article-title":"Association of Comorbid Substance Use Disorders and PTSD on Later Symptom Severity, Functioning, and Economic Outcomes Among Veterans Applying for Department of Veterans Affairs PTSD Disability Benefits: A Retrospective Cohort Study.","author":"Boudreaux","year":"2019","journal-title":"PsyArXiv."},{"issue":"3","key":"10.1016\/j.drugalcdep.2022.109356_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.15288\/jsad.2007.68.474","article-title":"The factor structure of the alcohol use disorders identification test (AUDIT)","volume":"68","author":"Doyle","year":"2007","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"8","key":"10.1016\/j.drugalcdep.2022.109356_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-016-0709-y","article-title":"Concurrent treatment of substance use and PTSD","volume":"18","author":"Flanagan","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109356_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/jts.22521","article-title":"A systematic review of the self-medication hypothesis in the context of posttraumatic stress disorder and comorbid problematic alcohol use","volume":"33","author":"Hawn","year":"2020","journal-title":"J. Trauma Stress."},{"key":"10.1016\/j.drugalcdep.2022.109356_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neubiorev.2021.05.022","article-title":"A unifying translational framework to advance treatment research for comorbid PTSD and substance use disorders","volume":"127","author":"Hien","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109356_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/00952990.2018.1456545","article-title":"A review of the alcohol use disorders identification test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: past issues and future directions","volume":"44","author":"Higgins-Biddle","year":"2018","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"10.1016\/j.drugalcdep.2022.109356_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsat.2015.01.008","article-title":"The psychometric properties of the drug use disorders identification test (DUDIT): a review of recent research","volume":"53","author":"Hildebrand","year":"2015","journal-title":"J. Subst. Abus. Treat."},{"issue":"8","key":"10.1016\/j.drugalcdep.2022.109356_bib11","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00213-020-05548-2","article-title":"Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials","volume":"237","author":"Jerome","year":"2020","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109356_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: A reconsideration and recent applications.","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harvard review of psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2022.109356_bib13","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.neuropharm.2011.07.007","article-title":"Stress modulation of drug self- administration: implications for addiction comorbidity with post-traumatic stress disorder","volume":"62","author":"Logrip","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.drugalcdep.2022.109356_bib14","first-page":"283","article-title":"Posttraumatic stress disorder and co\u2010occurring substance use disorders: Advances in assessment and treatment","volume":"19","author":"McCauley","year":"2012","journal-title":"Clin. Psychol.: Sci. Pract."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109356_bib15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"issue":"202","key":"10.1016\/j.drugalcdep.2022.109356_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2019.04.031","article-title":"Auditing the AUDIT: a systematic review of cut-off scores for the alcohol use disorders identification test (AUDIT) in low- and middle-income countries","author":"Nadkarni","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109356_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jclp.21980","article-title":"Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD","volume":"69","author":"Najavits","year":"2013","journal-title":"J. Clin. Psychol."},{"issue":"12","key":"10.1016\/j.drugalcdep.2022.109356_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia- suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2022.109356_bib19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0306-4603(95)00024-7","article-title":"Understanding comorbidity between PTSD and substance use disorder: two preliminary investigations","volume":"20","author":"Saladin","year":"1995","journal-title":"Addict. Behav."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109356_bib20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugalcdep.2022.109356_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0269881121991792","article-title":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder","volume":"35","author":"Sessa","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.drugalcdep.2022.109356_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-199606003-00015","article-title":"The measurement of disability","volume":"11","author":"Sheehan","year":"1996","journal-title":"Int Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109356_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jsat.2006.11.006","article-title":"Health problems of substance- dependent veterans with and those without trauma history","volume":"33","author":"Tate","year":"2007","journal-title":"J. Subst. Abus. Treat."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162200093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162200093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:23:50Z","timestamp":1759829030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687162200093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":23,"alternative-id":["S037687162200093X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109356","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109356"}}